Home/Filings/4/0001193125-25-203540
4//SEC Filing

Huber Reid M 4

Accession 0001193125-25-203540

CIK 0002012593other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 4:05 PM ET

Size

4.9 KB

Accession

0001193125-25-203540

Insider Transaction Report

Form 4
Period: 2025-09-12
Huber Reid M
Director
Transactions
  • Purchase

    Common Stock

    2025-09-12$24.48/sh+20,400$499,37420,400 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.23 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

Documents

1 file

Issuer

Rapport Therapeutics, Inc.

CIK 0002012593

Entity typeother

Related Parties

1
  • filerCIK 0001607052

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:05 PM ET
Size
4.9 KB